Fabtech Technologies Limited
Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 68 Cr | 121 Cr | 63 Cr | 159 Cr |
| Operating expenses (approx.) | 72 Cr | 88 Cr | 67 Cr | 127 Cr |
| EBITDA | -3 Cr | 33 Cr | -4 Cr | 32 Cr |
| OPM % | -5.1% | 27.4% | -6.9% | 20.1% |
| Other income | 0.95 Cr | 3 Cr | 7 Cr | 10 Cr |
| Interest | 1 Cr | 1 Cr | 0.87 Cr | 0.88 Cr |
| Depreciation | 1 Cr | 1 Cr | 1 Cr | 1 Cr |
| Profit before tax | -6 Cr | 31 Cr | -7 Cr | 30 Cr |
| Tax % | 1.1% | 10.2% | 15.4% | 26.3% |
| Net profit | -6 Cr | 28 Cr | -6 Cr | 22 Cr |
| EPS (₹) | ₹-1.89 | ₹8.68 | ₹-1.56 | ₹5.75 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 411 Cr | Sign in for TTM |
| Operating expenses (approx.) | 353 Cr | Sign in for TTM |
| EBITDA | 57 Cr | Sign in for TTM |
| OPM % | 14.0% | Sign in for TTM |
| Other income | 21 Cr | Sign in for TTM |
| Interest | 4 Cr | Sign in for TTM |
| Depreciation | 5 Cr | Sign in for TTM |
| Profit before tax | 48 Cr | Sign in for TTM |
| Tax % | 20.7% | Sign in for TTM |
| Net profit | 38 Cr | Sign in for TTM |
| EPS (₹) | ₹10.00 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 44 Cr |
| Reserves | 375 Cr |
| Borrowings | 42 Cr |
| Other liabilities | 192 Cr |
| Total liabilities | 204 Cr |
| Fixed assets (net) | 55 Cr |
| CWIP | — |
| Investments | 26 Cr |
| Other assets | 517 Cr |
| Total assets | 204 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 0.48 Cr |
| Cash from investing | -112 Cr |
| Cash from financing | 190 Cr |
| Net cash flow | 78 Cr |
| Free cash flow (OCF − Capex) | -4 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 11.3% |
| ROE % | 9.1% |
| Debtor days | — |
| Inventory days | 19 |
| Days payable | — |
| Cash conversion cycle | 19 |
| Debt / equity | 0.10 |
| Current ratio | 2.50 |
| Net debt / EBITDA | -0.78 |
Compare with peers
Loading peers…